NATIXIS ADVISORS, L.P. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
NATIXIS ADVISORS, L.P. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,155
+6.5%
26,026
+0.6%
0.01%
+11.1%
Q2 2023$2,962
-20.4%
25,866
-4.1%
0.01%
-30.8%
Q1 2023$3,719
+6.9%
26,985
+0.5%
0.01%0.0%
Q4 2022$3,480
-99.9%
26,854
+1.9%
0.01%
+8.3%
Q3 2022$2,913,000
+55.9%
26,348
+5.7%
0.01%
+50.0%
Q2 2022$1,869,000
-11.9%
24,932
-8.2%
0.01%0.0%
Q1 2022$2,121,000
-7.6%
27,150
+6.5%
0.01%
-11.1%
Q4 2021$2,296,000
+0.2%
25,494
+2.9%
0.01%0.0%
Q3 2021$2,291,000
+22.1%
24,770
+2.6%
0.01%0.0%
Q2 2021$1,876,000
+28.4%
24,136
+23.1%
0.01%
+12.5%
Q1 2021$1,461,000
-58.1%
19,609
-4.1%
0.01%
-60.0%
Q4 2020$3,485,000
+103.2%
20,441
+67.4%
0.02%
+81.8%
Q3 2020$1,715,000
-9.0%
12,210
+3.9%
0.01%
-15.4%
Q2 2020$1,884,000
+45.5%
11,749
-11.2%
0.01%
+18.2%
Q1 2020$1,295,000
-26.1%
13,235
-2.6%
0.01%
-8.3%
Q4 2019$1,753,00013,5870.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders